We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
+2.47%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$18.5B
AUM Growth
+$1.26B
Cap. Flow
+$569M
Cap. Flow %
3.08%
Top 10 Hldgs %
44.15%
Holding
64
New
8
Increased
19
Reduced
25
Closed
6

Top Buys

Rank Stock Value
1
NWL icon
Newell Brands
NWL
+$587M
2
WBA
Walgreens Boots Alliance
WBA
+$478M
3
CVS icon
CVS Health
CVS
+$396M
4
AGN
Allergan plc
AGN
+$207M
5
UHS icon
Universal Health Services
UHS
+$195M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$375M
2
ZBH icon
Zimmer Biomet
ZBH
+$369M
3
LOW icon
Lowe's Companies
LOW
+$235M
4
HCA icon
HCA Healthcare
HCA
+$225M
5
AAPL icon
Apple
AAPL
+$205M

Sector Composition

Rank Sector Weight
1 Healthcare 43.93%
2 Materials 12.42%
3 Technology 8.98%
4 Communication Services 8.9%
5 Consumer Discretionary 6.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCA icon
1
HCA Healthcare
HCA
$87.2B
$1.08B 5.86%
12,351,122
-2,804,820
-19% -$225M
DD icon
2
DuPont de Nemours
DD
$18.5B
$1.06B 5.75%
5,896,941
-515,446
-8% -$92.8M
FMC icon
3
FMC
FMC
$1.34B
$1.01B 5.46%
12,300,647
-1,213,890
-9% -$97.6M
SHPG
4
DELISTED
Shire pic
SHPG
$890M 4.81%
5,738,610
-130,528
-2% -$19.3M
IQV icon
5
IQVIA
IQV
$38.7B
$840M 4.54%
8,576,935
-344,421
-4% -$35.1M
FLEX icon
6
Flex
FLEX
$41.7B
$709M 3.83%
52,327,261
– –
ELV icon
7
Elevance Health
ELV
$81.5B
$688M 3.72%
3,057,497
-745,018
-20% -$159M
DXC icon
8
DXC Technology
DXC
$1.82B
$657M 3.55%
8,002,738
-1,037,117
-11% -$83.8M
TMO icon
9
Thermo Fisher Scientific
TMO
$213B
$632M 3.42%
3,327,576
+598,749
+22% +$115M
MCK icon
10
McKesson
MCK
$100B
$593M 3.21%
3,801,966
+1,081,088
+40% +$160M
CI icon
11
Cigna
CI
$73.7B
$532M 2.88%
2,619,078
-464,675
-15% -$92.5M
NWL icon
12
Newell Brands
NWL
$2.38B
$526M 2.84%
+17,012,932
New +$587M
GOOGL icon
13
Alphabet (Google) Class A
GOOGL
$4.36T
$518M 2.8%
9,835,040
-2,327,160
-19% -$120M
AET
14
DELISTED
Aetna Inc
AET
$518M 2.8%
2,869,460
-925,024
-24% -$159M
EBAY icon
15
eBay
EBAY
$50.6B
$501M 2.71%
13,269,082
+2,812,383
+27% +$104M
WBA
16
DELISTED
Walgreens Boots Alliance
WBA
$496M 2.68%
6,829,696
+6,780,296
+13,725% +$478M
CVS icon
17
CVS Health
CVS
$133B
$495M 2.67%
6,821,631
+5,452,628
+398% +$396M
UHS icon
18
Universal Health Services
UHS
$10.2B
$468M 2.53%
4,126,555
+1,827,071
+79% +$195M
FDC
19
DELISTED
First Data Corporation
FDC
$459M 2.48%
27,472,976
+10,503,544
+62% +$180M
LH icon
20
Labcorp
LH
$25B
$426M 2.3%
3,108,376
-276,755
-8% -$36.6M
PARA
21
DELISTED
Paramount Global Class B
PARA
$399M 2.16%
6,765,742
+197,840
+3% +$11.4M
CAR icon
22
Avis
CAR
$4.86B
$333M 1.8%
7,598,004
– –
WMB icon
23
Williams Companies
WMB
$87.5B
$309M 1.67%
10,149,408
+2,622,319
+35% +$76.3M
THC icon
24
Tenet Healthcare
THC
$20.5B
$271M 1.47%
17,895,314
+5,084
+0% +$71.6K
APTV icon
25
Aptiv
APTV
$12B
$249M 1.35%
2,935,720
+559,546
+24% +$53.3M
1
2 3

Similar funds

MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
LWCA
Locust Wood Capital Advisers New York $3.95B AUM 33.1% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
AS
American Securities New York $3.93B AUM 52.22% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $3.93B AUM 13.09% 1-Year Est. Return

Glenview Capital Management's Q4 2017 Portfolio in Review

As of Q4 2017, Glenview Capital Management held 64 positions worth $18.5B, up 7.3% from $17.2B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Glenview Capital Management deployed $569M of net new capital in Q4 2017, opening 8 new positions and adding to 19 existing holdings. Its largest new stake was Newell Brands: 17,012,932 shares worth $526M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 43% a quarter earlier, followed by Materials and Technology.

On the sell side, the largest reduction was AbbVie, an estimated $375M trimmed.

  • Glenview Capital Management's largest Q4 2017 buy was Newell Brands: 17,012,932 shares worth $526M.
  • Glenview Capital Management added most to Walgreens Boots Alliance in Q4 2017, an estimated $478M increase.
  • Glenview Capital Management's biggest Q4 2017 reduction was AbbVie, cutting an estimated $375M.
  • Glenview Capital Management fully exited Zimmer Biomet in Q4 2017, selling an estimated $369M.
  • Glenview Capital Management's ten largest holdings make up 44% of its $18.5B portfolio in Q4 2017.
  • Glenview Capital Management opened 8 new positions and closed 6 in Q4 2017.
  • Glenview Capital Management's portfolio value rose 7.3% quarter-over-quarter to $18.5B.

Based on Glenview Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.